Why is CERS Up Today?
About Cerus Corp
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INT...
Overall Confidence: 70%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector: +1.4%
Market Comparison
Quick Trade Ideas
Options strategies to consider for CERS's 9% move
No Options Available
CERS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get CERS Alerts
We'll notify you when CERS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
CERS has moved more than 3.0% up on 54 occasions in the past year.
Frequently Asked Questions
Why is CERS stock up today?
Options traders are heavily buying calls on CERS, with 81% of volume in calls. This suggests bullish institutional positioning.
Is CERS stock a buy or sell right now?
Based on current analysis, CERS shows 70% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the CERS stock price target?
CERS is currently trading at $2.14. Based on today's momentum, the expected short-term range is $2.09 - $2.20. See long-term price prediction →
Will CERS stock continue rising?
Our analysis shows a 45% probability that CERS's move continues in the next 1-3 days. Key level to watch: $2.24 (resistance).
Is CERS stock oversold or overbought?
CERS's RSI (Relative Strength Index) is currently at 40.4. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for CERS stock?
CERS's 10-day momentum indicator is at -0.35. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is CERS outperforming or underperforming the market?
CERS (+9.49%) is currently significantly outperforming the market (+8.3% vs SPY). Today, the S&P 500 (SPY) is up 1.23%, and Nasdaq (QQQ) is up 2.62%.
What does MACD indicate for CERS?
CERS's MACD (-0.09) is currently below the signal line (-0.06), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 24.2) is moderate.
Is CERS in an uptrend or downtrend?
Based on moving average analysis, CERS is in a bearish trend. The price ($2.14) is trading below both the 20-day SMA ($2.26) and 50-day SMA ($2.38). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis